Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Clinical trial NCT07596901 · RECRUITING

Trial details

NCT number: NCT07596901
Sponsor: Aurinia Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2026-04-22
Primary completion: 2029-03-02
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.